These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34463926)

  • 1. Curcumin Sensitizes Prolactinoma Cells to Bromocriptine by Activating the ERK/EGR1 and Inhibiting the AKT/GSK-3β Signaling Pathway In Vitro and In Vivo.
    Tang C; Zhu J; Yuan F; Yang J; Cai X; Ma C
    Mol Neurobiol; 2021 Dec; 58(12):6170-6185. PubMed ID: 34463926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bromocriptine and cabergoline induce cell death in prolactinoma cells via the ERK/EGR1 and AKT/mTOR pathway respectively.
    Tang C; Sun R; Wen G; Zhong C; Yang J; Zhu J; Cong Z; Luo X; Ma C
    Cell Death Dis; 2019 Apr; 10(5):335. PubMed ID: 31000722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of MAPK11/12/13/14 (p38 MAPK) protein in dopamine agonist-resistant prolactinomas.
    Wang S; Wang A; Zhang Y; Zhu K; Wang X; Chen Y; Wu J
    BMC Endocr Disord; 2021 Nov; 21(1):235. PubMed ID: 34814904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor suppressor miR-145-5p sensitizes prolactinoma to bromocriptine by downregulating TPT1.
    Jian M; Du Q; Zhu D; Mao Z; Wang X; Feng Y; Xiao Z; Wang H; Zhu Y
    J Endocrinol Invest; 2019 Jun; 42(6):639-652. PubMed ID: 30370446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bromocriptine Induces Autophagy-Dependent Cell Death in Pituitary Adenomas.
    Geng X; Ma L; Li Z; Li Z; Li J; Li M; Wang Q; Chen Z; Sun Q
    World Neurosurg; 2017 Apr; 100():407-416. PubMed ID: 28137551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin (diferuloylmethane) inhibits cell proliferation, induces apoptosis, and decreases hormone levels and secretion in pituitary tumor cells.
    Miller M; Chen S; Woodliff J; Kansra S
    Endocrinology; 2008 Aug; 149(8):4158-67. PubMed ID: 18450960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of SKP2 Sensitizes Bromocriptine-Induced Apoptosis in Human Prolactinoma Cells.
    Huang J; Zhang F; Jiang L; Hu G; Sun W; Zhang C; Ding X
    Cancer Res Treat; 2017 Apr; 49(2):358-373. PubMed ID: 27488872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PGAM5-CypD pathway is involved in bromocriptine-induced RIP3/MLKL-dependent necroptosis of prolactinoma cells.
    Zhang SL; Tang HB; Hu JT; Zang ZL; Ding X; Li S; Yang H
    Biomed Pharmacother; 2019 Mar; 111():638-648. PubMed ID: 30611988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pimozide augments bromocriptine lethality in prolactinoma cells and in a xenograft model via the STAT5/cyclin D1 and STAT5/Bcl‑xL signaling pathways.
    Xiao Z; Liang J; Deng Q; Song C; Yang X; Liu Z; Shao Z; Zhang K; Wang X; Li Z
    Int J Mol Med; 2021 Jan; 47(1):113-124. PubMed ID: 33155660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACT001 reverses resistance of prolactinomas via AMPK-mediated EGR1 and mTOR pathways.
    Zhu J; Tang C; Cong Z; Yuan F; Cai X; Yang J; Ma C
    Endocr Relat Cancer; 2021 Dec; 29(2):33-46. PubMed ID: 34821219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin and Nano-Curcumin Mitigate Copper Neurotoxicity by Modulating Oxidative Stress, Inflammation, and Akt/GSK-3β Signaling.
    Sarawi WS; Alhusaini AM; Fadda LM; Alomar HA; Albaker AB; Aljrboa AS; Alotaibi AM; Hasan IH; Mahmoud AM
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34577062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined treatment with artesunate and bromocriptine has synergistic anticancer effects in pituitary adenoma cell lines.
    Wang X; Du Q; Mao Z; Fan X; Hu B; Wang Z; Chen Z; Jiang X; Wang Z; Lei N; Wang H; Zhu Y
    Oncotarget; 2017 Jul; 8(28):45874-45887. PubMed ID: 28501857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine receptor D2S gene transfer improves the sensitivity of GH3 rat pituitary adenoma cells to bromocriptine.
    Li Q; Su Z; Liu J; Cai L; Lu J; Lin S; Xiong Z; Li W; Zheng W; Wu J; Zhuge Q; Wu Z
    Mol Cell Endocrinol; 2014 Jan; 382(1):377-384. PubMed ID: 24184771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin Ameliorates Lead-Induced Hepatotoxicity by Suppressing Oxidative Stress and Inflammation, and Modulating Akt/GSK-3β Signaling Pathway.
    Alhusaini A; Fadda L; Hasan IH; Zakaria E; Alenazi AM; Mahmoud AM
    Biomolecules; 2019 Nov; 9(11):. PubMed ID: 31694300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol inhibited GH3 cell growth and decreased prolactin level via estrogen receptors.
    Wang C; Hu ZQ; Chu M; Wang Z; Zhang WG; Wang LZ; Li CG; Wang JS
    Clin Neurol Neurosurg; 2012 Apr; 114(3):241-8. PubMed ID: 22104698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of TGF-β/Smad signaling in dopamine agonist-resistant prolactinomas.
    Li Z; Liu Q; Li C; Zong X; Bai J; Wu Y; Lan X; Yu G; Zhang Y
    Mol Cell Endocrinol; 2015 Feb; 402():64-71. PubMed ID: 25578603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin induces mitochondrial apoptosis in human hepatoma cells through BCLAF1-mediated modulation of PI3K/AKT/GSK-3β signaling.
    Bai C; Zhao J; Su J; Chen J; Cui X; Sun M; Zhang X
    Life Sci; 2022 Oct; 306():120804. PubMed ID: 35882275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of bromocriptine and terguride on cell proliferation and apoptosis in the estrogen-stimulated anterior pituitary gland of the rat.
    Yonezawa K; Tamaki N; Kokunai T
    Neurol Med Chir (Tokyo); 1997 Dec; 37(12):901-6. PubMed ID: 9465588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letrozole Decreased Testosterone-Induced Cell Proliferation and Prolactin Secretion also Increased Apoptosis in MMQ and GH3 Rat Prolactinoma Cell Lines.
    Selek A; Halbutoğulları ZSU; Aydemir Çİ; Cetinarslan B; Canturk Z; Tarkun I; Erman G; Subaşı C; Erdal K
    Mol Neurobiol; 2023 May; 60(5):2442-2454. PubMed ID: 36662360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration of G alpha subunits mRNA levels in bromocriptine resistant prolactinomas.
    Caccavelli L; Morange-Ramos I; Kordon C; Jaquet P; Enjalbert A
    J Neuroendocrinol; 1996 Oct; 8(10):737-46. PubMed ID: 8910802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.